Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma

Clinical trial NCT01555853 · TERMINATED

Trial details

NCT number: NCT01555853
Sponsor: Washington University School of Medicine
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin Hodgkin Disease

Start date: 2012-07-01
Primary completion: 2016-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.